J
Jacobson Pharma Corporation Ltd
HKEX:2633
Jacobson Pharma Corporation Ltd
HKEX:2633
Price:
1.25
HKD
Market Closed
Market Cap:
HK$2.5B
Relative Value
The Relative Value of one Jacobson Pharma Corporation Ltd stock under the Base Case scenario is 1.1 HKD. Compared to the current market price of 1.25 HKD, Jacobson Pharma Corporation Ltd is Overvalued by 12%.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
Relative Value
Base Case
1.1
HKD
Overvaluation 12%
J
Multiples Across Competitors
Competitors Multiples
Jacobson Pharma Corporation Ltd Competitors
Jacobson Pharma Corporation Ltd Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| HK |
J
|
Jacobson Pharma Corporation Ltd
HKEX:2633
|
2.5B HKD | 1.6 | 8.3 | 6.2 | 6.2 | |
| US |
|
Eli Lilly and Co
NYSE:LLY
|
1.1T USD | 17.6 | 56.9 | 38.1 | 40.9 | |
| US |
|
Johnson & Johnson
NYSE:JNJ
|
564.7B USD | 6 | 21 | 14.7 | 18 | |
| CH |
|
Roche Holding AG
SIX:ROG
|
284B CHF | 4.6 | 30.2 | 12.8 | 14.9 | |
| US |
|
Merck & Co Inc
NYSE:MRK
|
294.9B USD | 4.5 | 16.1 | 10.1 | 11.8 | |
| CH |
|
Novartis AG
SIX:NOVN
|
225.9B CHF | 5.2 | 20.2 | 12.7 | 16.4 | |
| UK |
|
AstraZeneca PLC
LSE:AZN
|
213.4B GBP | 5.1 | 31.7 | 15.1 | 22.1 | |
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
218B USD | 94 | -74.6 | 333.1 | 835.4 | |
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.3T DKK | 3.9 | 12 | 8.4 | 9.8 | |
| US |
|
Pfizer Inc
NYSE:PFE
|
153.2B USD | 2.4 | 19.6 | 7.3 | 9.8 | |
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
117.3B USD | 2.4 | 19.4 | 6.9 | 9 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
